Literature DB >> 28413659

Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis.

Katsuro Ichimasa1, Shin-Ei Kudo1, Hideyuki Miyachi1, Yuta Kouyama1, Fumio Ishida1, Toshiyuki Baba1, Atsushi Katagiri1, Kunihiko Wakamura1, Takemasa Hayashi1, Tomokazu Hisayuki1, Toyoki Kudo1, Masashi Misawa1, Yuichi Mori1, Shingo Matsudaira1, Yui Kimura1, Yuki Kataoka2.   

Abstract

Approximately 10% of patients with T1 colorectal cancer have lymph node metastases (LNM), requiring node dissection along with surgical resection. Patient gender was recently reported to affect the occurrence of LNM. The aim of the present study was to assess whether patient gender was predictive of LNM in T1 colorectal cancer. Public databases, including PubMed, EMBASE and the Cochrane Central Register of Controlled Trials were searched, using key terms related to 'T1 colorectal cancer' and 'lymph node'. All relevant studies reporting the adjusted odds ratio or risk ratio of LNM in relation to patient gender were included. The quality of the studies was classified according to the Quality in Prognostic Studies tool. A random-effects model was used and the quality of the evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation approach. The initial database search identified 2,492 publications; of those, 36 studies reported unadjusted results. Of the 36 studies, 4 reported adjusted results and fulfilled the inclusion criteria for this meta-analysis: 3 studies were graded as having a moderate risk of bias, and 1 had a low risk of bias. The present meta-analysis demonstrated that female gender was associated with increased risk of LNM (risk ratio=2.45, 95% confidence interval: 1.03-3.88). The I2 statistic was 0.901, classified as very low (+OOO) and was downgraded by the risk of bias, inconsistency and publication bias. In conclusion, female gender was found to be correlated with LNM in patients with T1 colorectal cancer.

Entities:  

Keywords:  T1 cancer; colorectal cancer; female; gender; lymph node metastasis

Year:  2017        PMID: 28413659      PMCID: PMC5374909          DOI: 10.3892/mco.2017.1172

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  66 in total

Review 1.  Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer.

Authors:  Hiroo Wada; Manabu Shiozawa; Kayoko Katayama; Naoyuki Okamoto; Yohei Miyagi; Yasushi Rino; Munetaka Masuda; Makoto Akaike
Journal:  J Gastroenterol       Date:  2015-03-01       Impact factor: 7.527

2.  Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer.

Authors:  Yuri Akishima-Fukasawa; Yukio Ishikawa; Yoshikiyo Akasaka; Miwa Uzuki; Naomi Inomata; Tomoko Yokoo; Ryuga Ishii; Reiko Shimokawa; Kiyoshi Mukai; Hideko Kiguchi; Koyu Suzuki; Mieko Fujiwara; Kentaro Ogata; Hitoshi Niino; Hitoshi Sugiura; Akihiro Ichinose; Yoshikazu Kuroda; Daisuke Kuroda; Toshiharu Ishii
Journal:  Histopathology       Date:  2011-09       Impact factor: 5.087

3.  Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.

Authors:  Huann-Sheng Wang; Wen-Yih Liang; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Shung-Haur Yang; Shih-Ching Chang; Jen-Kou Lin
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

4.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.

Authors:  P Roger; M E Sahla; S Mäkelä; J A Gustafsson; P Baldet; H Rochefort
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

5.  Immediate radical resection after local excision of rectal cancer: an oncologic compromise?

Authors:  Dieter Hahnloser; Bruce G Wolff; David W Larson; Jennifer Ping; Santhat Nivatvongs
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

6.  New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion.

Authors:  Tetsuya Shimomura; Shingo Ishiguro; Hideyuki Konishi; Naoki Wakabayashi; Shoji Mitsufuji; Tsutomu Kasugai; Masayuki Manou; Tadashi Kodama
Journal:  J Gastroenterol Hepatol       Date:  2004-01       Impact factor: 4.029

7.  Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

Authors:  P A Konstantinopoulos; A Kominea; G Vandoros; G P Sykiotis; P Andricopoulos; I Varakis; G Sotiropoulou-Bonikou; A G Papavassiliou
Journal:  Eur J Cancer       Date:  2003-06       Impact factor: 9.162

8.  Histopathologic determinants of regional lymph node metastasis in early colorectal cancer.

Authors:  Yukio Ishikawa; Yuri Akishima-Fukasawa; Kinji Ito; Yoshikiyo Akasaka; Tomoko Yokoo; Toshiharu Ishii
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

9.  Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines.

Authors:  R Kikuchi; M Takano; K Takagi; N Fujimoto; R Nozaki; T Fujiyoshi; Y Uchida
Journal:  Dis Colon Rectum       Date:  1995-12       Impact factor: 4.585

10.  Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.

Authors:  Akihito Abe; Hirokazu Fukui; Shigehiko Fujii; Mikio Fujita; Kenichiroh Mukawa; Kazuhito Ichikawa; Shigeki Tomita; Yuko Ono; Yasuo Imai; Johji Imura; Keiichi Kubota; Takahiro Fujimori
Journal:  J Gastroenterol Hepatol       Date:  2007-07       Impact factor: 4.029

View more
  6 in total

1.  Risk factors of recurrence in T1 colorectal cancers treated by endoscopic resection alone or surgical resection with lymph node dissection.

Authors:  Yuta Kouyama; Shin-Ei Kudo; Hideyuki Miyachi; Katsuro Ichimasa; Shingo Matsudaira; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Takemasa Hayashi; Kunihiko Wakamura; Fumio Ishida; Shigeharu Hamatani
Journal:  Int J Colorectal Dis       Date:  2018-05-11       Impact factor: 2.571

2.  TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY.

Authors:  Flávio Roberto Takeda; Francisco Tustumi; Bruna de Camargo Nigro; Rubens Antonio Aissar Sallum; Ulysses Ribeiro-Junior; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2019-12-20

3.  Nomogram based on homogeneous and heterogeneous associated factors for predicting distant metastases in patients with colorectal cancer.

Authors:  Tianwen Luo; Yutong Wang; Xuefeng Shan; Ye Bai; Chun Huang; Guangcan Li; Hongmei Wang
Journal:  World J Surg Oncol       Date:  2021-01-27       Impact factor: 2.754

4.  Construction of a Diagnostic Model for Lymph Node Metastasis of the Papillary Thyroid Carcinoma Using Preoperative Ultrasound Features and Imaging Omics.

Authors:  Chao Zhang; Lihua Cheng; Weiwen Zhu; Jian Zhuang; Tong Zhao; Xiaoqin Li; Wenfeng Wang
Journal:  J Healthc Eng       Date:  2022-02-08       Impact factor: 2.682

5.  Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.

Authors:  Luca Reggiani Bonetti; Valeria Barresi; Antonino Maiorana; Samantha Manfredini; Cecilia Caprera; Stefania Bettelli
Journal:  Dis Markers       Date:  2018-06-19       Impact factor: 3.434

6.  Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study.

Authors:  Kenichi Mochizuki; Shin-Ei Kudo; Katsuro Ichimasa; Yuta Kouyama; Shingo Matsudaira; Yuki Takashina; Yasuharu Maeda; Tomoyuki Ishigaki; Hiroki Nakamura; Naoya Toyoshima; Yuichi Mori; Masashi Misawa; Noriyuki Ogata; Toyoki Kudo; Takemasa Hayashi; Kunihiko Wakamura; Naruhiko Sawada; Fumio Ishida; Hideyuki Miyachi
Journal:  Int J Colorectal Dis       Date:  2020-06-16       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.